Medical device outsourcing market seen reaching $330.23 billion by 2030

The Business Research Company says the medical device outsourcing market will grow from $161.91 billion in 2025 to $186.82 billion in 2026, then nearly double again to $330.23 billion by 2030. The report points to remote patient monitoring, digital manufacturing and supply-chain resilience as key drivers shaping demand.

Why it matters: - Medical device makers are leaning more on outside partners to cut costs, speed launches and handle complex regulatory work. - The market’s projected growth signals sustained demand for contract manufacturing, development and compliance services across the healthcare supply chain. - Remote patient monitoring, wearable devices and connected health tools are expanding the need for specialized outsourcing capabilities.

What happened: - The Business Research Company published a medical device outsourcing market report on Aug. 17, 2026. - The report estimates the market will rise from $161.91 billion in 2025 to $186.82 billion in 2026. - The report projects the market will reach $330.23 billion by 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region through the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report offers a free sample and a full report.

The details: - Medical device outsourcing covers external help with product development, manufacturing and regulatory compliance. - The historical growth drivers include more complex regulations, higher in-house production costs, global expansion, faster product launch needs and more specialized outsourcing providers. - The forecast drivers include digital manufacturing, sustainable production, wearable and connected devices, scalable manufacturing and more resilient supply chains. - Key trends expected to shape the market include broader contract manufacturing, more regulatory and quality assurance support, more end-to-end development partnerships, more outsourcing in electronics and embedded systems, and continued cost reduction efforts. - The report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables. - One growth driver is rising demand for remote patient monitoring devices. - Remote patient monitoring systems collect and transmit health data from home or other remote locations. - The devices support continuous monitoring and can improve patient care. - Development of these connected devices, sensors and data analytics platforms relies heavily on outsourcing. - In August 2023, Vivalink reported survey results showing 84% of current users planned to increase remote patient monitoring use in 2024. - Vivalink also said 45% of healthcare providers were using remote patient monitoring in hospital-at-home programs for acute monitoring. - Vivalink said 77% expected RPM-based care to surpass traditional inpatient care within five years.

Between the lines: - The report points to a broader shift in medtech toward specialized suppliers handling more of the value chain. - Demand is moving beyond manufacturing alone and into regulatory support, embedded systems and full device-development partnerships. - The fastest growth is likely to come from regions and product categories tied to connected care, where technical complexity is highest.

What's next: - The market is expected to keep growing quickly through 2030 as connected devices and digital manufacturing become more central to medtech production. - Outsourcing providers with regulatory, software and electronics expertise are positioned to benefit most from the shift. - Regional investment in healthcare and manufacturing capacity should continue to support Asia-Pacific growth.